Client of a consultant lobbyist
Emergent BioSolutions Canada Inc.
- Meetings this Parliament
- 45
- With MPs
- 9
- Since Nov 2021
- 45
- Active registrations
- 1
Most recent reported meeting: Oct 23, 2026.
Lobbying by Emergent BioSolutions Canada Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingWho they meet
Since the current Parliament opened.
MPs
- Billy Morin Conservative 3
- Ben Carr Liberal 2
- Doug Eyolfson Liberal 2
- Rebecca Chartrand Liberal 1
- Terry Duguid Liberal 1
Institutions
- Innovation, Science and Economic Development Canada (ISED)21
- House of Commons8
- National Defence (DND)5
- Indigenous Services Canada (ISC)5
- Health Canada (HC)4
- Prairies Economic Development Canada (PrairiesCan)2
- Privy Council Office (PCO)1
- Prime Minister's Office (PMO)1
Registrations in effect
Consultant In effect since Oct 6, 2026
Consultant Kait LaForce of Counsel Public Affairs Inc.
Consultant lobbyists
-
Kait LaForce
Former public office holder
Formerly Manager, Office of Member of Parliament Filomena Tassi, House of Commons (2017–2018)
Formerly Writer, Liberal Research Bureau, House of Commons (2016–2017)
-
Kait LaForce
Former public office holder
Formerly Manager, Office of Member of Parliament Filomena Tassi, House of Commons (2017–2018)
Formerly Writer, Liberal Research Bureau, House of Commons (2016–2017)
-
Kait LaForce
Former public office holder
Formerly Manager, Office of Member of Parliament Filomena Tassi, House of Commons (2017–2018)
Formerly Writer, Liberal Research Bureau, House of Commons (2016–2017)
Institutions they may lobby: Canada Revenue Agency (CRA), Correctional Service of Canada (CSC), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Finance Canada (FIN), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), National Defence (DND), Prairies Economic Development Canada (PrairiesCan), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Safety Canada (PS), Royal Canadian Mounted Police (RCMP), Senate of Canada, Veterans Affairs Canada (VAC)
What they're lobbying on (8)Hide details
- Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
- Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
- Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats.
- To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
- Eligibility for Scientific Research and Experimental Development tax incentives.
- Discuss changes to take home naloxone program.
- Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
- Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
Registration 940796-382308-5. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Kait LaForce · Consultant
- Soha Samii · Regional Advisor for Western Canada, Innovation, Science and Economic Development Canada (ISED)
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Kait LaForce · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
- Alison McConnell · Deputy Director, Innovation, Science and Economic Development Canada (ISED)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
-
Reported by Kait LaForce · Consultant
- Shannon Ablett · Stakeholder Relations Manager, Privy Council Office (PCO)
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
-
Reported by Kait LaForce · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Kait LaForce · Consultant
- Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
- Alyth Roos · Special Assistant Policy, Prime Minister's Office (PMO)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
-
Reported by Kait LaForce · Consultant
- Blossom Leung · Senior Advisor, Indigenous Services Canada (ISC)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
-
Reported by Kait LaForce · Consultant
- Ben Carr · Member of Parliament
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by Kait LaForce · Consultant
- Jennifer Novak · Director General, Indigenous Services Canada (ISC)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
-
Reported by Kait LaForce · Consultant
- Harnoor Kochar · Regional Advisor, Indigenous Services Canada (ISC)
- Jennifer Novak · Director General, Indigenous Services Canada (ISC)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
-
Reported by Kait LaForce · Consultant
- Quinn Ferris · Regional Advisor, National Defence (DND)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by Kait LaForce · Consultant
- Billy Morin · Member of Parliament
Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget Read more
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
-
Reported by Kait LaForce · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Kait LaForce · Consultant
- Quinn Rinke · West and North Regional Advisor, National Defence (DND)
- Radey Barrack · Director of Policy, National Defence (DND)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by Kait LaForce · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
- Alison McConnell · Deputy Director, Innovation, Science and Economic Development Canada (ISED)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
-
Reported by Kait LaForce · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Kait LaForce · Consultant
- Terry Duguid · Member of Parliament
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Kait LaForce · Consultant
- Doug Eyolfson · Member of Parliament
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by Kait LaForce · Consultant
- Rebecca Chartrand · Minister of Northern and Arctic Affairs and Canadian and Northern Economic Development Agency, Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC)
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Kait LaForce · Consultant
- Ben Carr · Member of Parliament
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Kait LaForce · Consultant
- Timothy Smith · Deputy Program manager, National Defence (DND)
- Paul Eagan · Medical Consultant, National Defence (DND)
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
-
Reported by Kait LaForce · Consultant
- Morgan McCullough · Director of Operations, Finance Canada (FIN)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by Kait LaForce · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
- Allison Kwong · Junior Analyst, Innovation, Science and Economic Development Canada (ISED)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by Kait LaForce · Consultant
- Bryn Savage · Senior policy advisor, Health Canada (HC)
To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more
-
Reported by Kait LaForce · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats. Read more
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
-
Reported by Kait LaForce · Consultant
- Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures. Read more
Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.